Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03029598
Title Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Washington
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Carboplatin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.